Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1526 ARTÍCULOS , VIENDO DEL 1171 AL 1185

Correlation of Alzheimer Disease Neuropathologic Staging with Amyloid and Tau Scintigraphic Imaging Biomarkers

Koychev I, Hofer M, Friedman N.

J Nucl Med. 2020 Oct;61(10):1413-1418. doi: 10.2967/jnumed.119.230458. Epub 2020 Aug 6.

Comparing progression biomarkers in clinical trials of early Alzheimer's disease

Cullen NC, Zetterberg H, Insel PS, Olsson B, Andreasson U; Alzheimer’s Disease Neuroimaging Initiative; Blennow K, Hansson O, Mattsson-Carlgren N.

Ann Clin Transl Neurol. 2020 Sep;7(9):1661-1673. doi: 10.1002/acn3.51158. Epub 2020 Aug 11.

Associations of Green Tea Consumption and Cerebrospinal Fluid Biomarkers of Alzheimer's Disease Pathology in Cognitively Intact Older Adults: The CABLE Study

Ma YH, Wu JH, Xu W, Shen XN, Wang HF, Hou XH, Cao XP, Bi YL, Dong Q, Feng L, Tan L, Yu JT.

J Alzheimers Dis. 2020;77(1):411-421. doi: 10.3233/JAD-200410.

Exploration of Plasma Lipids in Mild Cognitive Impairment due to Alzheimer's Disease

Bergland AK, Proitsi P, Kirsebom BE, Soennesyn H, Hye A, Larsen AI, Xu J, Legido-Quigley C, Rajendran L, Fladby T, Aarsland D.

J Alzheimers Dis. 2020;77(3):1117-1127. doi: 10.3233/JAD-200441.

Erythrocytes as markers of oxidative stress related pathologies

Massaccesi L, Galliera E, Corsi Romanelli MM.

Mech Ageing Dev. 2020 Oct;191:111333. doi: 10.1016/j.mad.2020.111333. Epub 2020 Aug 16.

Age and the association between apolipoprotein E genotype and Alzheimer disease: A cerebrospinal fluid biomarker-based case-control study

Saddiki H, Fayosse A, Cognat E, Sabia S, Engelborghs S, Wallon D, Alexopoulos P, Blennow K, Zetterberg H, Parnetti L, Zerr I, Hermann P, Gabelle A, Boada M, Orellana A, de Rojas I, Lilamand M, Bjerke M, Van Broeckhoven C, Farotti L, Salvadori N, Diehl-Schmid J, Grimmer T, Hourregue C, Dugravot A, Nicolas G, Laplanche JL, Lehmann S, Bouaziz-Amar E; Alzheimer’s Disease Neuroimaging Initiative; Hugon J, Tzourio C, Singh-Manoux A, Paquet C, Dumurgier J.

PLoS Med. 2020 Aug 20;17(8):e1003289. doi: 10.1371/journal.pmed.1003289. eCollection 2020 Aug.

Revisiting the Amyloid Cascade Hypothesis: From Anti-Aβ Therapeutics to Auspicious New Ways for Alzheimer's Disease

Uddin MS, Kabir MT, Rahman MS, Behl T, Jeandet P, Ashraf GM, Najda A, Bin-Jumah MN, El-Seedi HR, Abdel-Daim MM.

Int J Mol Sci. 2020 Aug 14;21(16):5858. doi: 10.3390/ijms21165858.

Dickkopf-1 Overexpression in vitro Nominates Candidate Blood Biomarkers Relating to Alzheimer's Disease Pathology

Shi L, Winchester LM, Liu BY, Killick R, Ribe EM, Westwood S, Baird AL, Buckley NJ, Hong S, Dobricic V, Kilpert F, Franke A, Kiddle S, Sattlecker M, Dobson R, Cuadrado A, Hye A, Ashton NJ, Morgan AR, Bos I, Vos SJB, Ten Kate M, Scheltens P, Vandenberghe R, Gabel S, Meersmans K, Engelborghs S, De Roeck EE, Sleegers K, Frisoni GB, Blin O, Richardson JC, Bordet R, Molinuevo JL, Rami L, Wallin A, Kettunen P, Tsolaki M, Verhey F, Lleó A, Alcolea D, Popp J, Peyratout G, Martinez-Lage P, Tainta M, Johannsen P, Teunissen CE, Freund-Levi Y, Frölich L, Legido-Quigley C, Barkhof F, Blennow K, Rasmussen KL, Nordestgaard BG, Frikke-Schmidt R, Nielsen SF, Soininen H, Vellas B, Kloszewska I, Mecocci P, Zetterberg H, Morgan BP, Streffer J, Visser PJ, Bertram L, Nevado-Holgado AJ, Lovestone S.

J Alzheimers Dis. 2020;77(3):1353-1368. doi: 10.3233/JAD-200208.

Exosomes in Alzheimer's Disease: Potential Role as Pathological Mediators, Biomarkers and Therapeutic Targets

Lakshmi S, Essa MM, Hartman RE, Guillemin GJ, Sivan S, Elumalai P.

Neurochem Res. 2020 Nov;45(11):2553-2559. doi: 10.1007/s11064-020-03111-1. Epub 2020 Aug 25.

Extending Alzheimer disease biomarker studies into the Hispanic community

Bennett DA, Knopman DS.

Neurology. 2020 Oct 13;95(15):665-666. doi: 10.1212/WNL.0000000000010714. Epub 2020 Aug 26.

Sleep spindle abnormalities related to Alzheimer's disease: a systematic mini-review

Weng YY, Lei X, Yu J.

Sleep Med. 2020 Nov;75:37-44. doi: 10.1016/j.sleep.2020.07.044. Epub 2020 Aug 11.

Advancing medicine for Alzheimer's disease: A plasma neural exosome platform

Goetzl EJ.

FASEB J. 2020 Oct;34(10):13079-13084. doi: 10.1096/fj.202001655. Epub 2020 Aug 28.

Surface plasmon resonance biosensors for detection of Alzheimer's biomarkers; an effective step in early and accurate diagnosis

Rezabakhsh A, Rahbarghazi R, Fathi F.

Biosens Bioelectron. 2020 Nov 1;167:112511. doi: 10.1016/j.bios.2020.112511. Epub 2020 Aug 17.

Obstructive Sleep Apnea and Its Treatment in Aging: Effects on Alzheimer's disease Biomarkers, Cognition, Brain Structure and Neurophysiology

Mullins AE, Kam K, Parekh A, Bubu OM, Osorio RS, Varga AW.

Neurobiol Dis. 2020 Nov;145:105054. doi: 10.1016/j.nbd.2020.105054. Epub 2020 Aug 27.

Trying to get ahead of Alzheimer disease

Mandell BF.

Cleve Clin J Med. 2020 Aug 31;87(9):517-518. doi: 10.3949/ccjm.87b.09020.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias